Fujian Aonong Biological Technology Group Incorporation Limited (SHA:603363)

SHA:603363 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	696.9	1,384	207.66	719.08	542.98	570.94
Trading Asset Securities	1.29	1.81	4.6	2.61	1	1.39
Cash & Short-Term Investments	698.19	1,386	212.26	721.69	543.98	572.33
Cash Growth	82.68%	552.83%	-70.59%	32.67%	-4.95%	124.45%
Accounts Receivable	706.98	393.11	650.92	515.16	526.79	449.06
Other Receivables	898.31	739.1	246.9	258.02	266.97	327.77
Receivables	1,605	1,132	897.82	773.18	793.76	776.83
Inventory	887.77	816.94	1,328	3,289	2,589	1,731
Prepaid Expenses	-	0	0.08	0.03	0.04	0.02
Other Current Assets	330.83	364.34	350.82	331.74	336.59	444.32
Total Current Assets	3,522	3,699	2,789	5,115	4,263	3,524
Property, Plant & Equipment	4,261	4,424	8,691	11,078	10,702	6,662
Long-Term Investments	163.13	167.76	331.59	306.41	175.35	201.91
Goodwill	357.21	345.39	386.31	439.17	488.51	455.14
Other Intangible Assets	320.2	328.81	424.38	651.2	462.7	374.46
Long-Term Accounts Receivable	-	1.58	-	-	-	-
Long-Term Deferred Tax Assets	179.47	142.07	166.89	253.22	150.77	155.23
Long-Term Deferred Charges	156.47	159.57	335.89	354.11	320.94	414.2
Other Long-Term Assets	188.25	237.56	499.99	466.2	536.96	231.58
Total Assets	9,148	9,506	13,625	18,663	17,101	12,019
Accounts Payable	1,296	1,675	3,557	4,118	3,912	2,128
Accrued Expenses	74.35	148.09	230.08	404.46	330.34	204.85
Short-Term Debt	366.23	765.33	3,835	3,975	3,654	2,680
Current Portion of Long-Term Debt	474.29	410.58	1,209	1,079	380.77	180.44
Current Portion of Leases	-	94.54	662.62	813.06	702.36	194.58
Current Income Taxes Payable	24.38	7	15.02	27.63	16.38	17.19
Current Unearned Revenue	164.65	172.39	327.88	252.9	262.13	212.01
Other Current Liabilities	1,047	1,342	1,523	975.74	858.49	631.84
Total Current Liabilities	3,447	4,614	11,359	11,645	10,117	6,248
Long-Term Debt	1,587	1,462	1,182	1,579	2,916	1,445
Long-Term Leases	187.69	182.8	1,370	1,828	1,709	296.29
Long-Term Unearned Revenue	101.6	108.73	173.05	149.2	109.36	87.64
Long-Term Deferred Tax Liabilities	12.47	13.73	18.88	23.67	25.52	23.42
Other Long-Term Liabilities	27.57	63.36	25.16	3.94	30.56	15.37
Total Liabilities	5,363	6,445	14,128	15,229	14,908	8,115
Common Stock	2,603	2,606	870.27	871.06	684.41	674.02
Additional Paid-In Capital	5,352	5,004	3,776	3,664	1,535	1,483
Retained Earnings	-4,562	-4,976	-5,556	-1,905	-867.43	755.26
Treasury Stock	-	-17.56	-17.46	-81.9	-158.81	-147.19
Comprehensive Income & Other	-50.47	-49.85	-36.54	-42.86	110.07	-22.52
Total Common Equity	3,342	2,566	-962.97	2,506	1,303	2,742
Minority Interest	443.23	494.97	459.75	929.26	889.52	1,161
Shareholders' Equity	3,785	3,061	-503.22	3,435	2,193	3,903
Total Liabilities & Equity	9,148	9,506	13,625	18,663	17,101	12,019
Total Debt	2,615	2,915	8,259	9,273	9,362	4,796
Net Cash (Debt)	-1,917	-1,530	-8,047	-8,552	-8,818	-4,223
Net Cash Per Share	-0.89	-1.77	-9.28	-11.04	-13.58	-6.71
Filing Date Shares Outstanding	2,603	2,606	870.27	871.06	684.41	674.02
Total Common Shares Outstanding	2,603	2,606	870.27	871.06	684.41	674.02
Working Capital	75.29	-914.89	-8,570	-6,530	-5,854	-2,724
Book Value Per Share	1.28	0.98	-1.11	2.88	1.69	4.07
Tangible Book Value	2,665	1,892	-1,774	1,415	352.26	1,912
Tangible Book Value Per Share	1.02	0.73	-2.04	1.62	0.30	2.84
Buildings	-	3,102	4,825	4,827	4,170	-
Machinery	-	2,094	3,162	3,131	2,686	-
Construction In Progress	-	474.14	954.26	1,175	1,288	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.